Education & Training Programme (ETP) 2010
Sub-Committee chaired by Hervé Le Louet (ISoP Executive Committee member)
Contributions to this news page: Paula Marquez, Kenneth Hartigan-Go and Sophie Spence
History:
The 2003 Annual Meeting in Marrakech, Morocco, provided an excellent framework for creative new ideas. In this environment, the Executive Committee of the Society approved a new project, the new Education & Training Programme (ETP), in order to prepare a robust educational programme, available worldwide, to promote the safest use of drugs.
Some of the goals of the training and education activities for ISoP are:
- Efficient, effective and robust knowledge on the field of pharmacovigilance
- Worldwide coverage and flexibility to adapt to the changing environment, including the use of new technologies, new regulations and legal framework.
- Integration with WHO and other international initiatives (sharing best practices and resources) and local requirements to be included
- Training and enabling trainers (regional trainers to be trained).
This programme will also include recommendations to improve the communication about safety measures to health professionals and to patients.
The ETP programme team met during the 4th Annual Meeting of ISoP held in Dublin from 6-8 October 2004. The 20 active members are fully committed to working together for successful delivery of the goals of the project in a timely manner. The evidence for this enthusiasm was observed during the formal presentation in the workshop entitled "Communication and Education in Pharmacovigilance", as well as in the first face-to-face meeting.
The programme has covered a pilot phase where all pharmacovigilance activities in pre-graduate and postgraduate arenas have been collected and reviewed in 2 pilot countries ( Spain & UK ) through a preliminary questionnaire. The output provided relevant and important input in preparing for a more formal survey, to assess other member countries' needs and activities. Team members proposed to contact WHO centres and pharmaceutical industry subsidiaries to collect this information from all sites.
The team is also working in 3 additional areas:
- To identify funding sources. Educating people about Pharmacovigilance will promote safer drug use. Investment of resources is needed to develop adequate tools to achieve this goal.
- To educate and train the clients who will receive the most benefit from our project: health professionals, investigators and patients
- To evaluate possible accreditation through university, regulatory agencies (including EMEA and FDA, etc) considering current credit systems, and other types of accreditation.
The committee presented proposals in the fourth quarter of 2004 for the approval of the Executive Committee of ISoP in February 2005, and their progress was reviewed in the ETP meeting held in mid-October 2005 during the Annual Meeting was held in Manila, Philippines. This was the first meeting to be held in Asia.
During the Executive Committee meeting at the 2006 Annual Meeting in Liege, Belgium, Kenneth Hartigan-Go was nominated chair of the ETP and succeeded Paula Marquez.
This came after a successful mid-year training course was held in Seville, Spain in the first quarter of 2006.
In March 2007, ETP conducted a basic course in pharmacovigilance and an advanced course in immunopharmacology and ADR in Budapest.
The next ISoP mid-year PV course was held in Bangkok, Thailand from 17-18 March 2008, in partnership with Thai FDA and industry association. The courses included a basic PV and an advance course in pharmacogenomics and patient safety. A total of over 100 participants coming from Asia attended these courses.
A comprehensive PV curriculum covering 14 key sections is being prepared by Jurgen Beckman for ISoP to standardize education and training for the future. This is a work in progress.
In 2009, ETP courses were undertaken in Verona 26-27 March, again with the basic PV and an advanced PV course on risk management, plus a workshop on eco-pharmacovigilance. These courses were organized through the assistance of Prof. Giampaolo Velo and his team.
At the Annual Meeting of ISoP in Reims (ISoP 2009), the EC met and Hervé Le Louet succeeded Kenneth Hartigan-Go as ETP chair.
In Dec 2009, the ISoP ETP through the western pacific chapter assisted (Kenneth Hartigan-Go and Ian Boyd) and collaborated with Hanoi University of Pharmacy and Ministry of Health and conducted a two day basic course in PV for faculty and students and health professionals. A memorandum of agreement for future collaboration for human resource development is underway. See PV course report.
In March 2010, a training in partnership with Chinese University of Hong Kong, Department of Health and Hospital Authority will be undertaken at the Prince of Wales Hospital (local training).
In May 2010, Serbian colleagues from drug regulatory sectors are preparing for the mid-year ETP training courses (basic and Clinical Trial Safety courses).
|
